Aclaris Therapeutics
ACRS
ACRS
96 hedge funds and large institutions have $586M invested in Aclaris Therapeutics in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 100 → 96 (-4)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Holders
96
Holding in Top 10
2
Calls
$1.46M
Puts
$675K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$7.89M | |
| 3 | +$6.51M | |
| 4 |
BlackRock
New York
|
+$4.08M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.75M |
Top Sellers
| 1 | -$9.24M | |
| 2 | -$9.19M | |
| 3 | -$5.71M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$5.26M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.76M |